Ophthalmic Sutures Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Natural, Synthetic), By Application (Corneal transplantation surgery, Cataract surgery, Vitrectomy surgery, Iridectomy surgery, Oculoplastic surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others) Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 628.86 Million
CAGR (2026-2031)	6.45%
Fastest Growing Segment	Synthetic
Largest Market	North America
Market Size (2031)	USD 915.01 Million

Market Overview

The Global Ophthalmic Sutures Market will grow from USD 628.86 Million in 2025 to USD 915.01 Million by 2031 at a 6.45% CAGR. Ophthalmic sutures are specialized, ultra-fine surgical threads used to approximate ocular tissues with precision during surgeries involving the eye and its adnexa. Market growth is primarily driven by the expanding global geriatric population, which leads to a higher incidence of age-related conditions like glaucoma and corneal disorders requiring intervention. Furthermore, the rising prevalence of diabetic retinopathy and ocular trauma sustains the fundamental demand for these specific wound closure devices to ensure optimal postoperative healing.

A significant challenge impeding market expansion is the increasing adoption of sutureless techniques, such as self-sealing incisions and biocompatible adhesives, which reduce reliance on traditional closure methods. Despite this technological shift, the substantial volume of patients requiring care ensures a baseline demand. According to the International Agency for the Prevention of Blindness, in 2024, approximately 1.1 billion people globally were living with vision loss, highlighting the immense ongoing requirement for effective ophthalmic surgical interventions.

Key Market Drivers

The rapidly expanding global geriatric population serves as a primary catalyst for market growth, directly correlating with a surge in age-related ocular pathologies such as cataracts and glaucoma. As ocular tissues degenerate with age, the necessity for surgical intervention intensifies, requiring high-precision sutures for wound closure in complex procedures where self-sealing techniques are insufficient. This demographic shift is creating unprecedented pressure on healthcare systems to manage procedural backlogs, thereby sustaining the consumption rate of consumables. According to the Royal College of Ophthalmologists, May 2024, in the 'Progress on targets to increase elective activity' report, almost 600,000 patients were currently waiting for a first appointment with an ophthalmologist in England, underscoring the critical volume of surgical candidates entering the care pipeline.

Concurrently, the rising volume of corneal transplantation procedures is bolstering the consumption of specialized ophthalmic sutures, particularly given the reliance on varying suture patterns to secure donor grafts and manage astigmatism. Unlike standard cataract surgeries that may utilize sutureless incisions, keratoplasty necessitates the use of fine monofilament sutures to ensure graft stability and proper refractive outcomes. According to the Eye Bank Association of America, March 2024, in the '2023 Eye Banking Statistical Report', domestic keratoplasty procedures in the United States increased to 50,925 in 2023, reflecting a sustained upward trajectory in restorative surgeries. The commercial scale of the surgical sector supporting these interventions is evident in the financial performance of major industry players; according to Alcon, in 2024, surgical net sales reached $5.3 billion for the full year 2023, highlighting the substantial economic footprint of the ophthalmic surgical ecosystem.

Download Free Sample Report

Key Market Challenges

The increasing adoption of sutureless surgical techniques constitutes a primary restraint on the commercial expansion of the ophthalmic sutures market. Modern clinical practices have shifted toward minimally invasive procedures, particularly in cataract and refractive surgeries, where self-sealing incisions and biocompatible glues effectively replace traditional needle-and-thread closures. This transition is driven by the clinical need to minimize postoperative astigmatism, reduce inflammation, and accelerate patient rehabilitation times. As medical professionals prioritize these advanced methods to enhance surgical efficiency and patient comfort, the routine volume of sutures required for standard ocular interventions experiences a measurable decline.

The impact of this technological displacement is most profound in high-volume procedures that historically utilized sutures but now largely operate without them. The sheer scale of surgeries transitioning to these alternative closure methods significantly reduces the addressable market for conventional threading products. According to the American Academy of Ophthalmology in 2024, surgeons perform approximately 4 million cataract surgeries annually in the United States. The predominance of sutureless phacoemulsification within such a vast number of procedures illustrates how modern technique evolution directly limits the demand for traditional wound closure devices.

Key Market Trends

Advancements in suture needle geometry and metallurgy are reshaping the market as manufacturers engineer ultra-fine needles capable of maintaining structural integrity during delicate ocular microsurgeries. This trend addresses the clinical requirement for needles that resist bending when penetrating calcified or fibrotic tissues while minimizing trauma to the corneal or scleral layers. Innovators are increasingly utilizing advanced tempering processes and stainless steel alloys to produce needle tips with superior ductility and sharpness retention, which are essential for high-precision maneuvers in glaucoma and retinal procedures. According to Corza Medical, October 2024, in the 'Corza Medical Launches Next-Generation Microsurgical Sutures' press release, the company unveiled its Onatec portfolio, which utilizes highly tempered stainless steel to deliver enhanced bending resistance and needle accuracy for microsurgical applications.

Concurrently, the oculoplastic segment is witnessing a rising adoption of knotless and specialized suture technologies driven by the demand for superior aesthetic outcomes in periorbital surgeries. Surgeons are shifting towards advanced closure systems that eliminate palpable knots, which can cause granulomas or patient discomfort, while ensuring even tension distribution across the incision to reduce scarring. This technological integration is heavily supported by the surging global volume of eyelid rejuvenation procedures, creating a substantial addressable market for cosmetic-focused wound closure devices. According to the International Society of Aesthetic Plastic Surgery, June 2024, in the 'Global Survey on Aesthetic/Cosmetic Procedures 2023', eyelid surgery recorded over 1.7 million procedures globally, reflecting a 24% increase from the previous year and underscoring the expanding scale of the oculoplastic sector.

Segmental Insights

The synthetic segment is currently recognized as the fastest-growing category within the global ophthalmic sutures market. This accelerated expansion is primarily driven by the enhanced biocompatibility and superior tensile strength of synthetic materials compared to natural alternatives. Surgeons increasingly favor synthetic options, such as nylon or polypropylene, as they significantly reduce the risk of postoperative inflammation and infection. Furthermore, stringent safety guidelines from regulatory organizations like the U.S. FDA encourage the adoption of materials that offer consistent performance and predictable absorption rates. Consequently, the demand for these dependable sutures continues to rise alongside the increasing volume of delicate eye surgeries.

Regional Insights

North America maintains a dominant position in the global ophthalmic sutures market, driven primarily by the rising prevalence of ocular disorders that require surgical intervention. The region benefits from a well-established healthcare system and high patient awareness regarding vision care. Data from the National Eye Institute indicates a steady increase in cataract and glaucoma cases, which directly influences the demand for effective wound closure solutions. Additionally, the U.S. Food and Drug Administration provides a structured regulatory framework that facilitates product approvals, ensuring a consistent supply of approved medical devices to meet the surgical needs of the population.

Recent Developments

• In March 2025, BVI Medical completed a strategic capital raise of $1 billion in partnership with TPG and other investors to support its continued expansion in the global ophthalmic device market. The substantial investment was intended to refinance existing debt and provide fresh capital for accelerating new product launches and scaling manufacturing capabilities across its portfolio, which includes microsurgical sutures and intraocular lenses. This financial strengthening positioned the company to better compete with major industry players and drive the development of advanced surgical technologies that address the evolving needs of eye care professionals and patients.
• In October 2024, Corza Medical launched its new line of Onatec ophthalmic microsurgical sutures at the American Academy of Ophthalmology conference in Chicago. This product introduction marked a significant expansion of the company's ophthalmic surgery portfolio, offering surgeons a comprehensive range of precision-engineered needles and sutures designed for delicate eye procedures. The launch underscored the company's commitment to innovation in the ophthalmic space, aiming to provide high-performance wound closure solutions that offer superior handling and tissue outcomes for ophthalmologists performing complex microsurgeries worldwide.
• In September 2024, Mani, Inc. established a new sales subsidiary in the United States, Mani Medical America, Inc., to directly strengthen its client relationships and expand its market share in the eyeless needle and ophthalmic instrument segments. Concurrently, the company reinforced its strategic alliance with Microsurgical Technology to enhance the global distribution of its specialized surgical products. These initiatives were part of a broader strategy to transition from a dealer-based model to a direct sales approach in North America, aiming to capture a larger portion of the ophthalmic suture needle market by targeting key accounts and improving supply chain efficiency.
• In July 2024, Advanced Medical Solutions Group (AMS) completed the acquisition of Peters Surgical, a leading global provider of specialty surgical sutures and internal hemostatic devices. This strategic transaction significantly strengthened the company's position in the global wound closure market, adding a complementary portfolio of ophthalmic sutures and expanding its direct sales capabilities in key territories such as France, Germany, and the Asia-Pacific region. The integration of Peters Surgical was designed to enhance the company's operational footprint and drive growth through a broader range of high-quality surgical solutions for hospital and specialty clinic customers.

Key Market Players

• Medtronic Plc
• Accutome Inc.
• Asset Medical Sarl
• Alcon Inc.
• Aurolab
• B Braun Melsungen AG
• DemeTech Corporation
• FCI Ophthalmic Inc.
• Surgical Specialties Corp
• Teleflex Incorporated

By Type	By Application	By End User	By Region
Natural Synthetic	Corneal transplantation surgery Cataract surgery Vitrectomy surgery Iridectomy surgery Oculoplastic surgery Others	Hospitals Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Ophthalmic Sutures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Ophthalmic Sutures Market, By Type:

• Natural
• Synthetic

• Ophthalmic Sutures Market, By Application:

• Corneal transplantation surgery
• Cataract surgery
• Vitrectomy surgery
• Iridectomy surgery
• Oculoplastic surgery
• Others

• Ophthalmic Sutures Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Others

• Ophthalmic Sutures Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE